Thermo Fisher Scientific TMO Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Consolidated revenues by Business | ||||||
| Analytical Instruments | $7.55B0.0% | $7.55B+0.4% | $7.53B+1.1% | $7.44B-0.7% | $7.49B+0.4% | |
| Laboratory Products and Biopharma Services | $24.38B+1.7% | $23.98B+1.9% | $23.54B+1.0% | $23.31B— | —— | |
| Life Sciences Solutions | $10.67B+2.8% | $10.37B+3.4% | $10.03B+2.0% | $9.83B+1.5% | $9.69B+0.6% | |
| Specialty Diagnostics | $4.67B-0.1% | $4.68B+1.4% | $4.61B+1.0% | $4.57B+0.4% | $4.55B+0.9% | |
| Consolidated revenues by Product | ||||||
| Consumables | $19.03B+2.0% | $18.66B+2.8% | $18.16B+1.7% | $17.86B+1.4% | $17.61B+0.1% | |
| Instruments | $7.23B-1.0% | $7.3B-0.4% | $7.33B+0.6% | $7.29B-2.1% | $7.45B0.0% | |
| Service revenues | $18.94B+1.9% | $18.59B+1.9% | $18.25B+1.0% | $18.07B+1.3% | $17.84B0.0% | |
| Consolidated revenues by Geography | ||||||
| Asia-Pacific | $8.18B+1.0% | $8.1B+0.9% | $8.03B+1.1% | $7.94B-0.6% | $7.99B+0.4% | |
| Europe | $12.16B+2.8% | $11.83B+4.2% | $11.35B+2.9% | $11.03B+1.5% | $10.86B0.0% | |
| North America | $23.23B+0.8% | $23.03B+1.1% | $22.79B+0.4% | $22.69B+0.9% | $22.5B0.0% | |
| Other regions | $1.63B+2.2% | $1.6B+1.5% | $1.57B+1.2% | $1.56B+0.3% | $1.55B-0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Thermo Fisher Scientific break its business down?
- Thermo Fisher Scientific (TMO) reports consolidated revenues by business across 4 parts — Analytical Instruments, Laboratory Products and Biopharma Services, Life Sciences Solutions and Specialty Diagnostics. Each is extracted from the segment footnotes and tracked over time.
- Where does Thermo Fisher Scientific's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Thermo Fisher Scientific's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
